We determined the prevalence of human papillomavirus (HPV) by DNA chip test in 549 women and cytologic diagnosis. 237 of 549 women (43.17%) subjected with HPV DNA Chip examination were found positive for HPV. 210 (88.60%, High group) were infected with high-risk HPV types. 17 (7.17%, Low group) were infected with low-risk HPV types (6, 11, 40, 44, 70) and 17 (7.17%, Mixed group) were infected with mixed types. According to age, in their twenties, thirties, forties, fifties and over sixties, the prevalence of infection with high-risk HPV types were 1.26% (3/237), 15.61% (37/237), 31.65% (75/237), 23.21% (55/237), and 13.92% (33/237), respectively. In the Low and Mixed group, percentages of infection with HPV were significantly lower than that of the High group. On the comparison of cytologic diagnosis (224 women) by Pap smear and DNA chip positive (237 women) for HPV, 132 out of 194 cases in the High group (68.04%) suffered cervical lesions with ASCUS (atypical squamous cells of undetermined significance, 7.22%), LSIL (low grade squamous intraepithelial lesion, 15.98%), HSIL (high grade SIL, 23.20%) and ICC (invasive cervical cancer, 21.65%). The Low group (14/224 women) showed 1 case of ASCUS and 6 cases of LSIL, whereas the Mixed group (4/224 women) had only 2 cases of ASCUS. According to the HPV subtypes, the high-risk types 16 and 18 induced 26 and 7 cases of ICC, respectively, whereas other HPV subtypes induced lower or no ICC incidence. In conclusion, the present data imply that the prevalence of HPV was 43.17%, high-risk HPV type 16 is a major factor, which causes precancerous and/or cervical cancer in woman and that HPV DNA chip is an accurate and useful tool for detecting HPV.
Introduction
The development of the Pap smear by Papanicolaou has contributed to reduce morbidity and mortality in patients with cervical cancer. It is unquestionable that the Pap smear is the best example of a successful cervical cancer screening [12, 13] . However, the Pap smear test has a limitation with false negative although it is an excellent screening test. Sherman et al. [15] showed that ASCUS (atypical squamous cells of undetermined significance) cytology reports are not reproducible, even by expert cytopathologists. Several studies demonstrated that even though the majority of ASCUS findings by Pap smear represents a benign reactive process, 5 to 10% of the women with ASCUS have potential for HSIL (high grade squamous intraepithelial lesion) [4, 9, 17] . Human papillomavirus, which is sexually transmitted, is a strong agent of cervical cancer [18] . HPV can infect basal epithelial cells of the skin or inner lining of tissues and are classified as cutaneous type and mucosal type. Cutaneous types are epidermitrophic and target the skin of the hands and feet, while mucosal types infect the lining of the mouth, throat, respiratory tract, or genital epithelium. Methods for detecting HPV include PCR, in situ hybridization, Hybrid-Capture II assay, and HPV DNA chip test. Although HAP DNA chip test has merits such as identification for 22 to 24 genotypes of HPV, it has been less used compared with Hybrid-Capture II assay. However, we do not have enough data for studies of HPV DNA chip in Korea.
This study was carried out to investigate the prevalence of human papillomavirus (HPV) by DNA chip test in 549 women and cytologic diagnosis.
Materials and Methods

Patients
In 2006, 549 women were tested for human papillomavirus (HPV) by DNA chip. 237 women having tested positive on the HPV DNA chip test were subjected to this study. A cytologic test was carried out for 224 out of 237 women. Finally, the data of 224 patients were analyzed in the present study. Cytologic diagnosis was determined by Pap smear.
Cytologic diagnosis
Specimens were collected by scraping the endocervix and ectocervix with a brush.
The specimens were smeared on a slide glass and immediately immersed in 95% alcohol for test. The Pap stain procedure was the following : the specimen on the slide glass was fixed in 95% alcohol for 30 min and washed in tap water. The Nucleus in the specimen was stained with Harris' hematoxylin (Sigma, America), decolorized with 1% HCL-alcohol and neutralized in tap water for 10 min. The Cytoplasm was stained with orange G (Young Dong Diagnostics., Korea) for 2 min and with EA 50 (Young dong Co., Korea) for 2 min. The specimen was hydrated in absolute alcohol and mounted with Synthetic Mountant (Shandon, England).
Pathologists interpreted the results of the specimen and classified them with TBS (the Bethesda system).
HPV DNA chip test
A specimen was taken by cytobrush of HPV DNA chip sampler (BioMed Lab., Korea) from the endocervix and ectocervix and inserted into a transfer medium. The HPV DNA chip test was performed as follows.
DNA isolation
The specimen was isolated from cytobrush by strong vortexing and inserted into a microcentrifuge tube of 1.5 ml.
It was centrifuged with 8,800 rpm for 10 min and the super- 
Interpretation
The HPV type was determined by scanning (ScanArray Gx, PerkinElmer, America) after air drying at room temperature.
Results and Discussion
Cytologic diagnosis (Fig. 5) . Overall, the prevalence of ASCUS and LSIL was highest in the age group 40 years, and that of HSIL was highest in age group 30 years with vigorous sexual activity. The patients in the age group 50 years suffered invasive cervical carcinoma because they may have a menopausal disorder or they may be going through menopause.
Our findings were different from previous studies. Hong et al. [5] reported lower prevalence of abnormal findings than our results. They investigated subjects with and without HPV infection. However, Hwang [6] showed similar results in his study on women with HPV infection. 
HPV DNA test
If patients were infected with HPV, a fluorescent color can be seen (Fig. 6 ). 237 of 549 women (43.17%) subjected to the HPV DNA Chip examination were found positive for HPV. Incidences of HPV infection were summarized in Table   2 . Among 237 cases, 203 cases (85.65%) were high-risk HPV infections and were comprised of single infections (with one subtype), infections with two, three, and four subtypes. In 
Mixed types (case, %)
High single+low High multiple+low Total (n=12) single and two-types infections, patients in their forties had the highest incidence, in three-and four-type infections patients in their thirties had the highest prevalence. These data suggest that age group 30 and 40 years with energetic sexual activity may be exposed to more risk of HPV infection. On the other hand, 17 cases (7.17%) were identified as low-risk HPV infections. The highest incidence was in patients in their forties. Mixed types (with single infections high-risk and low-risk HPV or multiple infections high-risk and low-risk HPV) and unidentified type infections were re-spectively found in 12 (5.06%) and 5 (2.10%) cases. In all cases, age group 40 years had the highest prevalence of HPV infections. These results were similar to previous studies.
Muñoz et al. [11] demonstrated the highest prevalence of both groups in women in their 40s with and without squamous-cell cervical cancer. Hong et al. [5] explained that patients aged between 35 to 54 years were highly infected with HPV. Furthermore, Kim et al. [8] found that women in the 40 years age group had the highest HPV detection and HSIL.
However, Lazacano-Ponce et al., [10] whom investigated on Also, Stoler [16] described that age group 20 years in American women had the highest prevalence of HPV infection.
These discrepancies among several studies may be attributed to social or sexual cultural backgrounds.
Comparison of cytologic diagnosis with prevalence of HPV infection
Relationships between high-and low-risk HPV subtypes are described in Tables 3, 4 (Table 4 ). On the other hand, low-risk HPV cases with LHIL showed the highest incidence of subtype 70 (10%) ( Table 5 ).
The results of the present study agree with previous studies, in the fact that high-risk HPV subtype 16 causes cervical cancer. An [1] , Hong et al. [5] , Hwang [6] , Kahng and Lee [7] , Kim et al. [8] and Muñoz et al. [10] demonstrated a consistent finding that women with various cervical lesions including invasive squamous cancer had the highest prevalence of HPV subtype 16 infection. Rozendaal et al. [14] revealed that women with normal cervical smears containing high-risk HPV genotypes were 116 times more at risk of developing CIN (cervical intraepithelial neoplasia) III compared with women without high-risk HPV. Although the prevalence of HPV DNA associated with invasive cervical carcinoma differs among countries, the most common HPV types in invasive cervical cancer were, in order of decreasing prevalence, HPV 16, 18, 45, 31, 33, 58, 52, 35, 59, 56, 6, 51,  68, 39, 82, 73, 66 and 70. In squamous cell carcinoma, HPV subtype 16 was the predominant type (46-63%) followed by HPV subtype 18 (10-14%), 45 (2-8%), 31 (2-7%) and 33 (3-5%) in all regions except Asia, where HPV subtypes 58 (6%) and 52 (4%) were more frequently detected. In adeno-and adenosquamous-carcinoma, the HPV prevalence was significantly lower (76.4%) than in squamous cell carcinoma (87.3%), and HPV subtype 18 was predominant in every region (37-41%), followed by subtypes 16 (26-36%) and 45 (5-7%) [3] . Bosch et al. [2] found that 80-95% of patients suffering cervical cancer were infected with 5 subtypes such as HPV 16, 18, 31, 33, and 45. We support Bosch group's report by observing similar results.
In summary, the prevalence of HPV was 43.17%. Women with high-risk HPV subtype, especially type 16 infection, may be exposed to higher risk of cervical lesions and thus regularly routine HPV test with DNA Chip for women will appear to be useful for protection and prognosis of cervical cancer.
